Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From bedside to bench to bedside to clinical practice: an odyssey with irinotecan.

Literature DB >> 16551845

From bedside to bench to bedside to clinical practice: an odyssey with irinotecan.

Mark J Ratain¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2006 PMID： 16551845 DOI： 10.1158/1078-0432.CCR-06-0159

Source DB: PubMed Journal: Clin Cancer Res ISSN： 1078-0432 Impact factor: 12.531

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal: J Clin Oncol Date: 2010-06-07 Impact factor: 44.544

Review 2. Patient profiling for treatment toxicity: potential use of clinical and genomic factors.

Authors: Terri S Armstrong; Mark R Gilbert
Journal: Curr Oncol Rep Date: 2011-02 Impact factor: 5.075

Review 3. Pharmacogenomics: challenges and opportunities.

Authors: Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal: Ann Intern Med Date: 2006-11-21 Impact factor: 25.391

Review 4. Pharmacogenomic discovery using cell-based models.

Authors: Marleen Welsh; Lara Mangravite; Marisa Wong Medina; Kelan Tantisira; Wei Zhang; R Stephanie Huang; Howard McLeod; M Eileen Dolan
Journal: Pharmacol Rev Date: 2009-12 Impact factor: 25.468

Review 5. Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Authors: Christine M Hartford; M Eileen Dolan
Journal: Pharmacogenomics Date: 2007-09 Impact factor: 2.533

Review 6. Irinotecan pharmacogenomics.

Authors: Sharon Marsh; Janelle M Hoskins
Journal: Pharmacogenomics Date: 2010-07 Impact factor: 2.533

7. Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.

Authors: Zheng Liu; Jennifer H Martin; Winston Liauw; Sue-Anne McLachlan; Emma Link; Anetta Matera; Michael Thompson; Michael Jefford; Rod J Hicks; Carleen Cullinane; Athena Hatzimihalis; Ian Campbell; Simone Crowley; Phillip J Beale; Christos S Karapetis; Timothy Price; Mathew E Burge; Michael Michael
Journal: Eur J Clin Pharmacol Date: 2021-09-04 Impact factor: 2.953